Liu, Yuzhong https://orcid.org/0000-0001-5614-1951
Zhao, Xixi
Gan, Fei https://orcid.org/0000-0003-1670-5251
Chen, Xiaoyue
Deng, Kai https://orcid.org/0000-0003-2937-8931
Crowe, Samantha A.
Hudson, Graham A.
Belcher, Michael S.
Schmidt, Matthias https://orcid.org/0000-0002-3363-4777
Astolfi, Maria C. T. https://orcid.org/0000-0001-6995-2497
Kosina, Suzanne M. https://orcid.org/0000-0003-2885-1248
Pang, Bo
Shao, Minglong
Yin, Jing https://orcid.org/0000-0002-0029-5393
Sirirungruang, Sasilada https://orcid.org/0000-0002-2624-5124
Iavarone, Anthony T.
Reed, James https://orcid.org/0000-0001-5780-6134
Martin, Laetitia B. B. https://orcid.org/0000-0002-6921-7246
El-Demerdash, Amr https://orcid.org/0000-0001-6459-2955
Kikuchi, Shingo https://orcid.org/0000-0001-9033-6242
Misra, Rajesh Chandra https://orcid.org/0000-0001-9594-3789
Liang, Xiaomeng
Cronce, Michael J.
Chen, Xiulai
Zhan, Chunjun
Kakumanu, Ramu
Baidoo, Edward E. K.
Chen, Yan
Petzold, Christopher J. https://orcid.org/0000-0002-8270-5228
Northen, Trent R. https://orcid.org/0000-0001-8404-3259
Osbourn, Anne https://orcid.org/0000-0003-2195-5810
Scheller, Henrik
Keasling, Jay D. https://orcid.org/0000-0003-4170-6088
Article History
Received: 23 March 2023
Accepted: 22 March 2024
First Online: 8 May 2024
Competing interests
: J.D.K. has a financial interest in Amyris, Demetrix, Maple Bio, Lygos, Napigen, Berkeley Yeast, Zero Acre Farms, Ansa Biotechnologies, Apertor Pharmaceuticals, ResVit Bio, and Cyklos Materials. J.R., L.B.B.M. and A.O. are inventors of patents arising from work on QS-21 pathway characterization.